- Home
- RIGL vs VPG Comparison
RIGL vs VPG Comparison
Compare RIGL & VPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- VPG
- Stock Information
- Founded
- RIGL 1996
- VPG 2009
- Country
- RIGL United States
- VPG United States
- Employees
- RIGL N/A
- VPG N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- VPG Electrical Products
- Sector
- RIGL Health Care
- VPG Technology
- Exchange
- RIGL Nasdaq
- VPG Nasdaq
- Market Cap
- RIGL 335.5M
- VPG 340.4M
- IPO Year
- RIGL 2000
- VPG N/A
- Fundamental
- Price
- RIGL $18.98
- VPG $28.61
- Analyst Decision
- RIGL Buy
- VPG Hold
- Analyst Count
- RIGL 5
- VPG 1
- Target Price
- RIGL $36.40
- VPG $31.00
- AVG Volume (30 Days)
- RIGL 206.5K
- VPG 119.5K
- Earning Date
- RIGL 08-05-2025
- VPG 08-05-2025
- Dividend Yield
- RIGL N/A
- VPG N/A
- EPS Growth
- RIGL N/A
- VPG N/A
- EPS
- RIGL 2.08
- VPG 0.23
- Revenue
- RIGL $203,077,000.00
- VPG $297,480,000.00
- Revenue This Year
- RIGL $14.41
- VPG N/A
- Revenue Next Year
- RIGL $15.97
- VPG $6.38
- P/E Ratio
- RIGL $9.41
- VPG $123.45
- Revenue Growth
- RIGL 70.16
- VPG N/A
- 52 Week Low
- RIGL $8.10
- VPG $18.57
- 52 Week High
- RIGL $29.82
- VPG $35.11
- Technical
- Relative Strength Index (RSI)
- RIGL 45.79
- VPG 57.40
- Support Level
- RIGL $18.24
- VPG $27.69
- Resistance Level
- RIGL $19.38
- VPG $29.80
- Average True Range (ATR)
- RIGL 0.77
- VPG 1.12
- MACD
- RIGL -0.04
- VPG 0.04
- Stochastic Oscillator
- RIGL 43.64
- VPG 66.82
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About VPG Vishay Precision Group Inc.
Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.